Free Trial

HC Wainwright's Rating of PMI on 5/18/2026

On May 18, 2026, HC Wainwright updated its outlook on PMI (NYSEAMERICAN:PMI) with the action "Initiated Coverage", setting a "Neutral" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
6/12/2026
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
Boost Price Target
6/12/2026
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
Reiterated Rating
6/12/2026
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
Reiterated Rating
6/11/2026
Humacyte, Inc. stock logo
HUMA
Humacyte
Boost Price Target
6/11/2026
Oculis Holding AG stock logo
OCS
Oculis
Reiterated Rating
6/11/2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
Reiterated Rating
More Ratings From HC Wainwright